Alzheimer's Association to evaluate clinical utility of amyloid imaging

The Alzheimer's Association launched a four-year study to evaluate the clinical utility and health outcomes associated with using positron emission tomography (PET) of amyloid deposits in the brain to help diagnose Alzheimer's disease (AD).

The two-part Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) study will assess the effect of amyloid imaging on short-term clinical decision-making and longer-term medical outcomes. The study will evaluate changes to physicians' treatment plans by comparing intended treatment plans before PET scans with the resulting plans 90 days after imaging. ...